Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2024

Open Access 01-12-2024 | ST-Segment Elevation Myocardial Infarction | Research

Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study

Authors: Juan Wang, Lu-lu Wang, Yan-min Yang, Hui-qiong Tan, Jun Zhu

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Background

Given the increasing attention to glycemic variability (GV) and its potential implications for cardiovascular outcomes. This study aimed to explore the impact of acute GV on short-term outcomes in Chinese patients with ST-segment elevation myocardial infarction (STEMI).

Methods

This study enrolled 7510 consecutive patients diagnosed with acute STEMI from 274 centers in China. GV was assessed using the coefficient of variation of blood glucose levels. Patients were categorized into three groups according to GV tertiles (GV1, GV2, and GV3). The primary outcome was 30-day all-cause death, and the secondary outcome was major adverse cardiovascular events (MACEs). Cox regression analyses were conducted to determine the independent correlation between GV and the outcomes.

Results

A total of 7136 patients with STEMI were included. During 30-days follow-up, there was a significant increase in the incidence of all-cause death and MACEs with higher GV tertiles. The 30-days mortality rates were 7.4% for GV1, 8.7% for GV2 and 9.4% for GV3 (p = 0.004), while the MACEs incidence rates was 11.3%, 13.8% and 15.8% for the GV1, GV2 and GV3 groups respectively (p < 0.001). High GV levels during hospitalization were significantly associated with an increased risk of 30-day all-cause mortality and MACEs. When analyzed as a continuous variable, GV was independently associated with a higher risk of all-cause mortality (hazard ratio [HR] 1.679, 95% confidence Interval [CI] 1.005–2.804) and MACEs (HR 2.064, 95% CI 1.386–3.074). Additionally, when analyzed as categorical variables, the GV3 group was found to predict an increased risk of MACEs, irrespective of the presence of diabetes mellitus (DM).

Conclusion

Our study findings indicate that a high GV during hospitalization was significantly associated with an increased risk of 30-day all-cause mortality and MACE in Chinese patients with STEMI. Moreover, acute GV emerged as an independent predictor of increased MACEs risk, regardless of DM status.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. LANCET DIABETES ENDO. 2019;7(3):221–30.CrossRef Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. LANCET DIABETES ENDO. 2019;7(3):221–30.CrossRef
2.
go back to reference Rodbard D. Glucose variability: a review of clinical applications and Research Developments. DIABETES TECHNOL THE. 2018;20(S2):S25–215.CrossRef Rodbard D. Glucose variability: a review of clinical applications and Research Developments. DIABETES TECHNOL THE. 2018;20(S2):S25–215.CrossRef
3.
go back to reference Wu N, Shen H, Liu H, Wang Y, Bai Y, Han P. Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo. CARDIOVASC DIABETOL. 2016;15(1):109.CrossRefPubMedPubMedCentral Wu N, Shen H, Liu H, Wang Y, Bai Y, Han P. Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo. CARDIOVASC DIABETOL. 2016;15(1):109.CrossRefPubMedPubMedCentral
4.
go back to reference Valente T, Arbex AK. Glycemic variability, oxidative stress, and impact on complications related to type 2 diabetes Mellitus. CURR DIABETES REV. 2021;17(7):e01394260216.CrossRef Valente T, Arbex AK. Glycemic variability, oxidative stress, and impact on complications related to type 2 diabetes Mellitus. CURR DIABETES REV. 2021;17(7):e01394260216.CrossRef
5.
go back to reference Hsu JC, Yang YY, Chuang SL, Huang KC, Lee JK, Lin LY. Long-term visit‐to‐visit glycemic variability as a predictor of major adverse Limb and Cardiovascular events in patients with diabetes. J AM HEART ASSOC 2023, 12(3). Hsu JC, Yang YY, Chuang SL, Huang KC, Lee JK, Lin LY. Long-term visit‐to‐visit glycemic variability as a predictor of major adverse Limb and Cardiovascular events in patients with diabetes. J AM HEART ASSOC 2023, 12(3).
6.
go back to reference Ren X, Wang Z, Guo C. Long-term glycemic variability and risk of stroke in patients with diabetes: a meta-analysis. DIABETOL METAB SYNDR 2022, 14(1). Ren X, Wang Z, Guo C. Long-term glycemic variability and risk of stroke in patients with diabetes: a meta-analysis. DIABETOL METAB SYNDR 2022, 14(1).
7.
go back to reference Kapłan C, Kalemba A, Krok M, Krzych A. Effect of Treatment and Nutrition on Glycemic Variability in critically ill patients. Int J Environ Res Public Health. 2022;19(8):4717.CrossRefPubMedPubMedCentral Kapłan C, Kalemba A, Krok M, Krzych A. Effect of Treatment and Nutrition on Glycemic Variability in critically ill patients. Int J Environ Res Public Health. 2022;19(8):4717.CrossRefPubMedPubMedCentral
8.
go back to reference Belli M, Bellia A, Sergi D, Barone L, Lauro D, Barillà F. Glucose variability: a new risk factor for cardiovascular disease. ACTA DIABETOL. 2023;60(10):1291–9.CrossRefPubMedPubMedCentral Belli M, Bellia A, Sergi D, Barone L, Lauro D, Barillà F. Glucose variability: a new risk factor for cardiovascular disease. ACTA DIABETOL. 2023;60(10):1291–9.CrossRefPubMedPubMedCentral
9.
go back to reference Stalikas N, Papazoglou AS, Karagiannidis E, Panteris E, Moysidis D, Daios S, Anastasiou V, Patsiou V, Koletsa T, Sofidis G, et al. Association of stress induced hyperglycemia with angiographic findings and clinical outcomes in patients with ST-elevation myocardial infarction. CARDIOVASC DIABETOL. 2022;21(1):140.CrossRefPubMedPubMedCentral Stalikas N, Papazoglou AS, Karagiannidis E, Panteris E, Moysidis D, Daios S, Anastasiou V, Patsiou V, Koletsa T, Sofidis G, et al. Association of stress induced hyperglycemia with angiographic findings and clinical outcomes in patients with ST-elevation myocardial infarction. CARDIOVASC DIABETOL. 2022;21(1):140.CrossRefPubMedPubMedCentral
10.
go back to reference Humos B, Mahfoud Z, Dargham S, Al SJ, Jneid H, Abi KC. Hypoglycemia is associated with a higher risk of mortality and arrhythmias in ST-elevation myocardial infarction, irrespective of diabetes. FRONT CARDIOVASC MED. 2022;9:940035.CrossRefPubMedPubMedCentral Humos B, Mahfoud Z, Dargham S, Al SJ, Jneid H, Abi KC. Hypoglycemia is associated with a higher risk of mortality and arrhythmias in ST-elevation myocardial infarction, irrespective of diabetes. FRONT CARDIOVASC MED. 2022;9:940035.CrossRefPubMedPubMedCentral
11.
go back to reference Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care. 2008;31(Suppl 2):S150–4.CrossRefPubMed Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care. 2008;31(Suppl 2):S150–4.CrossRefPubMed
12.
go back to reference Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Lange M, Brown-Frandsen K, Moses A, Ocampo FA, et al. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61(1):48–57.CrossRefPubMed Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Lange M, Brown-Frandsen K, Moses A, Ocampo FA, et al. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61(1):48–57.CrossRefPubMed
13.
go back to reference Mi S, Su G, Yang H, Zhou Y, Tian L, Zhang T, Tao H. Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention. DIABETOL METAB SYNDR 2017, 9(1). Mi S, Su G, Yang H, Zhou Y, Tian L, Zhang T, Tao H. Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention. DIABETOL METAB SYNDR 2017, 9(1).
14.
go back to reference Zhang JW, He LJ, Cao SJ, Yang Q, Yang SW, Zhou YJ. Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions. DIABETOL METAB SYNDR. 2014;6:76.CrossRefPubMedPubMedCentral Zhang JW, He LJ, Cao SJ, Yang Q, Yang SW, Zhou YJ. Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions. DIABETOL METAB SYNDR. 2014;6:76.CrossRefPubMedPubMedCentral
15.
go back to reference Yang CD, Shen Y, Ding FH, Yang ZK, Hu J, Shen WF, Zhang RY, Lu L, Wang XQ. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI. CARDIOVASC DIABETOL. 2020;19(1):131.CrossRefPubMedPubMedCentral Yang CD, Shen Y, Ding FH, Yang ZK, Hu J, Shen WF, Zhang RY, Lu L, Wang XQ. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI. CARDIOVASC DIABETOL. 2020;19(1):131.CrossRefPubMedPubMedCentral
16.
go back to reference Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031–7.CrossRefPubMed Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031–7.CrossRefPubMed
17.
go back to reference Pu Z, Lai L, Yang X, Wang Y, Dong P, Wang D, Xie Y, Han Z. Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis. Endocrine. 2020;67(3):526–34.CrossRefPubMed Pu Z, Lai L, Yang X, Wang Y, Dong P, Wang D, Xie Y, Han Z. Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis. Endocrine. 2020;67(3):526–34.CrossRefPubMed
18.
go back to reference Zhang L, Li F, Liu H, Zhang Z, Yang F, Qian L, Wang R. Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome. Diabetes Vascular Disease Res. 2022;19(6):2033504433.CrossRef Zhang L, Li F, Liu H, Zhang Z, Yang F, Qian L, Wang R. Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome. Diabetes Vascular Disease Res. 2022;19(6):2033504433.CrossRef
19.
go back to reference Yi M, Cao Q, Tang WH, Liu Q, Ke X. Day-to‐day fasting plasma glucose variability on the short‐term prognosis of ST‐segment elevation myocardial infarction: a retrospective cohort study. CLIN CARDIOL. 2022;45(12):1246–54.CrossRefPubMedPubMedCentral Yi M, Cao Q, Tang WH, Liu Q, Ke X. Day-to‐day fasting plasma glucose variability on the short‐term prognosis of ST‐segment elevation myocardial infarction: a retrospective cohort study. CLIN CARDIOL. 2022;45(12):1246–54.CrossRefPubMedPubMedCentral
20.
go back to reference Deravi N, Sharifi Y, Koohi F, Zadeh SST, Masrouri S, Azizi F, Hadaegh F. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies. BMC Public Health 2023, 23(1). Deravi N, Sharifi Y, Koohi F, Zadeh SST, Masrouri S, Azizi F, Hadaegh F. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies. BMC Public Health 2023, 23(1).
21.
go back to reference Gerbaud E, De La Bouchard A, Baudinet T, Montaudon M, Beauvieux M, Lemaître A, Cetran L, Seguy B, Picard F, Vélayoudom F, et al. Glycaemic variability and hyperglycaemia as prognostic markers of Major Cardiovascular events in Diabetic patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart failure. J CLIN MED. 2022;11(6):1549.CrossRefPubMedPubMedCentral Gerbaud E, De La Bouchard A, Baudinet T, Montaudon M, Beauvieux M, Lemaître A, Cetran L, Seguy B, Picard F, Vélayoudom F, et al. Glycaemic variability and hyperglycaemia as prognostic markers of Major Cardiovascular events in Diabetic patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart failure. J CLIN MED. 2022;11(6):1549.CrossRefPubMedPubMedCentral
22.
go back to reference Chang S, Xu M, Wang Y, Zhang Y. Acute Glycemic variability and early outcomes after cardiac surgery: a Meta-analysis. HORM METAB RES; 2023. Chang S, Xu M, Wang Y, Zhang Y. Acute Glycemic variability and early outcomes after cardiac surgery: a Meta-analysis. HORM METAB RES; 2023.
23.
go back to reference Zheng Q, Liu X, Lan H, Guo Q, Xiong T, Wang K, Jiang C, Zhang J, Wang G, Dong N, et al. Association of fasting blood glucose variability with all-cause mortality in heart transplant recipients. CLIN Transpl. 2023;37(8):e14958.CrossRef Zheng Q, Liu X, Lan H, Guo Q, Xiong T, Wang K, Jiang C, Zhang J, Wang G, Dong N, et al. Association of fasting blood glucose variability with all-cause mortality in heart transplant recipients. CLIN Transpl. 2023;37(8):e14958.CrossRef
24.
go back to reference Li W, Wang Y, Zhong G. Glycemic variability and the risk of atrial fibrillation: a meta-analysis. FRONT ENDOCRINOL 2023, 14. Li W, Wang Y, Zhong G. Glycemic variability and the risk of atrial fibrillation: a meta-analysis. FRONT ENDOCRINOL 2023, 14.
25.
go back to reference Li X, Zhang D, Chen Y, Ye W, Wu S, Lou L, Zhu Y. Acute glycemic variability and risk of mortality in patients with sepsis: a meta-analysis. DIABETOL METAB SYNDR 2022, 14(1). Li X, Zhang D, Chen Y, Ye W, Wu S, Lou L, Zhu Y. Acute glycemic variability and risk of mortality in patients with sepsis: a meta-analysis. DIABETOL METAB SYNDR 2022, 14(1).
26.
go back to reference Kim SH, Kim JY, Kim ES, Park IR, Ha EY, Chung SM, Moon JS, Yoon JS, Won KC, Lee HW. Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia. ANN MED. 2022;54(1):2736–43.CrossRefPubMedPubMedCentral Kim SH, Kim JY, Kim ES, Park IR, Ha EY, Chung SM, Moon JS, Yoon JS, Won KC, Lee HW. Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia. ANN MED. 2022;54(1):2736–43.CrossRefPubMedPubMedCentral
27.
go back to reference Dong M, Liu W, Luo Y, Li J, Huang B, Zou Y, Liu F, Zhang G, Chen J, Jiang J et al. Glycemic variability is independently Associated with Poor Prognosis in five Pediatric ICU centers in Southwest China. FRONT NUTR 2022, 9. Dong M, Liu W, Luo Y, Li J, Huang B, Zou Y, Liu F, Zhang G, Chen J, Jiang J et al. Glycemic variability is independently Associated with Poor Prognosis in five Pediatric ICU centers in Southwest China. FRONT NUTR 2022, 9.
28.
go back to reference Su Y, Fan W, Liu Y, Hong K. Glycemic variability and in-hospital death of critically ill patients and the role of ventricular arrhythmias. CARDIOVASC DIABETOL 2023, 22(1). Su Y, Fan W, Liu Y, Hong K. Glycemic variability and in-hospital death of critically ill patients and the role of ventricular arrhythmias. CARDIOVASC DIABETOL 2023, 22(1).
29.
go back to reference Jiao X, Wang H, Li M, Lu Y. Glycemic variability and prognosis of patients with Intracerebral Hemorrhage: a Meta-analysis. HORM METAB RES. 2023;55(3):176.CrossRefPubMed Jiao X, Wang H, Li M, Lu Y. Glycemic variability and prognosis of patients with Intracerebral Hemorrhage: a Meta-analysis. HORM METAB RES. 2023;55(3):176.CrossRefPubMed
30.
go back to reference Lu J, Wang C, Cai J, Shen Y, Chen L, Zhang L, Lu W, Zhu W, Hu G, Xia T, et al. Association of HbA1c with all-cause Mortality Across varying degrees of glycemic variability in type 2 diabetes. J CLIN ENDOCR METAB. 2021;106(11):3160–7.CrossRefPubMedPubMedCentral Lu J, Wang C, Cai J, Shen Y, Chen L, Zhang L, Lu W, Zhu W, Hu G, Xia T, et al. Association of HbA1c with all-cause Mortality Across varying degrees of glycemic variability in type 2 diabetes. J CLIN ENDOCR METAB. 2021;106(11):3160–7.CrossRefPubMedPubMedCentral
31.
go back to reference Alfieri V, Myasoedova VA, Vinci MC, Rondinelli M, Songia P, Massaiu I, Cosentino N, Moschetta D, Valerio V, Ciccarelli M, et al. The role of Glycemic Variability in Cardiovascular disorders. Int J Mol Sci. 2021;22(16):8393.CrossRefPubMedPubMedCentral Alfieri V, Myasoedova VA, Vinci MC, Rondinelli M, Songia P, Massaiu I, Cosentino N, Moschetta D, Valerio V, Ciccarelli M, et al. The role of Glycemic Variability in Cardiovascular disorders. Int J Mol Sci. 2021;22(16):8393.CrossRefPubMedPubMedCentral
32.
go back to reference Yamazaki M, Hasegawa G, Majima S, Mitsuhashi K, Fukuda T, Iwase H, Kadono M, Asano M, Senmaru T, Tanaka M, et al. Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers. DIABETOL METAB SYNDR. 2014;6:54.CrossRefPubMedPubMedCentral Yamazaki M, Hasegawa G, Majima S, Mitsuhashi K, Fukuda T, Iwase H, Kadono M, Asano M, Senmaru T, Tanaka M, et al. Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers. DIABETOL METAB SYNDR. 2014;6:54.CrossRefPubMedPubMedCentral
33.
go back to reference Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. CARDIOVASC DIABETOL. 2021;20(1):9.CrossRefPubMedPubMedCentral Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. CARDIOVASC DIABETOL. 2021;20(1):9.CrossRefPubMedPubMedCentral
34.
go back to reference Amiel SA, Aschner P, Childs B, Cryer PE, de Galan BE, Frier BM, Gonder-Frederick L, Heller SR, Jones T, Khunti K, et al. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(5):385–96.CrossRef Amiel SA, Aschner P, Childs B, Cryer PE, de Galan BE, Frier BM, Gonder-Frederick L, Heller SR, Jones T, Khunti K, et al. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(5):385–96.CrossRef
35.
go back to reference Hanajima Y, Iwahashi N, Kirigaya J, Horii M, Minamimoto Y, Gohbara M, Abe T, Okada K, Matsuzawa Y, Kosuge M et al. Prognostic importance of glycemic variability on left ventricular reverse remodeling after the first episode of ST-segment elevation myocardial infarction. CARDIOVASC DIABETOL 2023, 22(1). Hanajima Y, Iwahashi N, Kirigaya J, Horii M, Minamimoto Y, Gohbara M, Abe T, Okada K, Matsuzawa Y, Kosuge M et al. Prognostic importance of glycemic variability on left ventricular reverse remodeling after the first episode of ST-segment elevation myocardial infarction. CARDIOVASC DIABETOL 2023, 22(1).
36.
go back to reference Bennetsen SL, Feineis CS, Legaard GE, Lyngbæk M, Karstoft K, Ried-Larsen M. The impact of physical activity on glycemic variability assessed by continuous glucose monitoring in patients with type 2 diabetes Mellitus: a systematic review. FRONT ENDOCRINOL. 2020;11:486.CrossRef Bennetsen SL, Feineis CS, Legaard GE, Lyngbæk M, Karstoft K, Ried-Larsen M. The impact of physical activity on glycemic variability assessed by continuous glucose monitoring in patients with type 2 diabetes Mellitus: a systematic review. FRONT ENDOCRINOL. 2020;11:486.CrossRef
37.
go back to reference Jaggers JR, King KM, McKay T, Dyess RJ, Thrasher BJ, Wintergerst KA. Association between intensity levels of physical activity and glucose variability among children and adolescents with type 1 diabetes. Int J Environ Res Public Health. 2023;20(2):1623.CrossRefPubMedPubMedCentral Jaggers JR, King KM, McKay T, Dyess RJ, Thrasher BJ, Wintergerst KA. Association between intensity levels of physical activity and glucose variability among children and adolescents with type 1 diabetes. Int J Environ Res Public Health. 2023;20(2):1623.CrossRefPubMedPubMedCentral
38.
go back to reference Vijayakumar V, Mavathur R, Kannan S, Sharma MNK, Raguram N, Kuppusamy M. Effect of yoga on reducing glycaemic variability in individuals with type 2 diabetes: a randomised controlled trial. DIABETES METAB. 2023;49(4):101457.CrossRefPubMed Vijayakumar V, Mavathur R, Kannan S, Sharma MNK, Raguram N, Kuppusamy M. Effect of yoga on reducing glycaemic variability in individuals with type 2 diabetes: a randomised controlled trial. DIABETES METAB. 2023;49(4):101457.CrossRefPubMed
39.
go back to reference Canelli R, Louca J, Hartman C, Bilotta F. Preoperative carbohydrate load to reduce perioperative glycemic variability and improve surgical outcomes: a scoping review. World J Diabetes. 2023;14(6):783–94.CrossRefPubMedPubMedCentral Canelli R, Louca J, Hartman C, Bilotta F. Preoperative carbohydrate load to reduce perioperative glycemic variability and improve surgical outcomes: a scoping review. World J Diabetes. 2023;14(6):783–94.CrossRefPubMedPubMedCentral
40.
go back to reference Færch K, Blond MB, Bruhn L, Amadid H, Vistisen D, Clemmensen K, Vainø C, Pedersen C, Tvermosegaard M, Dejgaard TF, et al. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D trial): a multi-arm, randomised, controlled trial. Diabetologia. 2021;64(1):42–55.CrossRefPubMed Færch K, Blond MB, Bruhn L, Amadid H, Vistisen D, Clemmensen K, Vainø C, Pedersen C, Tvermosegaard M, Dejgaard TF, et al. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D trial): a multi-arm, randomised, controlled trial. Diabetologia. 2021;64(1):42–55.CrossRefPubMed
Metadata
Title
Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study
Authors
Juan Wang
Lu-lu Wang
Yan-min Yang
Hui-qiong Tan
Jun Zhu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-024-02250-x

Other articles of this Issue 1/2024

Cardiovascular Diabetology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.